Latest news with #WorldCongressonADHD
Business Wire
02-06-2025
- Business
- Business Wire
Qbtech Expands US Presence with Formation of New Houston-Based Teams and Staff Appointments
HOUSTON--(BUSINESS WIRE)-- Qbtech, the global leader in objective ADHD testing, announces the formation of its Houston-based clinical research and strategic partnership teams, along with new staff appointments and promotions at the company's US headquarters. The employee expansions bolster the company's continued growth in the region, enhancing its capabilities and market presence as it continues to develop and enhance its software solutions. Former clinical research manager Ragini Sanyal has been promoted to Head of Clinical Research, with Jonas Bäckström joining as Chief Strategic Partnership Officer and Jack Smith as Head of US Commercial Operations. As Head of Clinical Research, Sanyal will lead the formalized clinical research team and its efforts to study the clinical utility and validity of objective ADHD assessments for diagnosing ADHD and its benefits in post-treatment follow-up. 'I truly believe objective ADHD technology is a guiding light through the uncertainty of the mental health space. I'm so excited to take on this role and lead our newly structured clinical research team to curate and share the data behind our objective assessments and how they can be used to progress ADHD care,' says Sanyal. 'This new team structure allows us to streamline our efforts across clinical operations, data management, medical writing, and trial execution. It will also help simplify decision-making, improve cross-functional collaboration, and provide a clearer focus as we continue to expand both our team and our portfolio. Coming off the World Congress on ADHD, I am so proud that our team was able to present four meaningful posters, and I can only imagine what we will accomplish in the coming months and years.' Jonas Bäckström, a former member of Qbtech's Board of Directors, has joined as Chief Strategic Partnership Officer, leading the newly established partnerships department from the Houston office. He brings a strong background in digital innovation, having worked with a pioneering digital healthcare provider in Sweden prior to joining Qbtech. 'This is an exciting opportunity for both me and Qbtech,' says Bäckström. 'I look forward to focusing on building scalable, evidence-based business models in the ADHD space and linking telehealth innovation with clinical, payer, and employer ecosystems. With my experience in business development and digital health, I am eager to help our partners achieve sustainable growth, improve patient outcomes, and shape a smarter, more accountable future for mental health, starting with ADHD.' Jack Smith will serve as Head of US Commercial Operations, leading efforts across sales and clinical support to drive Qbtech's expansion and identify new growth opportunities. A military veteran, Smith has served in various roles within the healthcare industry for more than 25 years. "I'm thrilled to be joining Qbtech at such a pivotal time in the US ADHD market. My goal is to build a world-class sales team that delivers real value to clinicians by driving improved patient outcomes through objective, evidence-based tools,' says Smith. 'As awareness grows and underserved markets expand, we have a unique opportunity to empower physicians with the confidence they need to make accurate ADHD diagnoses." The Qbtech team plans to hire additional staff in the Houston office throughout the year. Available career opportunities can be found at Qbtech is a privately-owned Swedish company that has developed leading solutions and products for improving the identification, diagnosis, treatment, and follow-up of patients living with ADHD. Qbtech has operations in 14 countries and has offices in Stockholm, Houston, and London. Qbtech is an award-winning company recognized for its innovation, most recently winning the 2022 HSJ Partnership Award for the 'Best Mental Health Partnership with the NHS.' For more information about Qbtech, visit
Associated Press
01-05-2025
- Health
- Associated Press
Mentavi Health to Present Study Validating Its Online Assessment for Diagnosing Adult ADHD at Major International Conference
Mentavi, a national leader in online mental health testing, will attend the 10th World Congress on ADHD and present a first-ever study comparing the accuracy and validity of an online asynchronous assessment for diagnosing ADHD in adults with the current standard of care, a clinical interview. GRAND RAPIDS, MICHIGAN / ACCESS Newswire / May 1, 2025 / Mentavi Health will present new clinical data highlighting the validation of its proprietary online assessment for diagnosing attention-deficit/hyperactivity disorder (ADHD) in adults at a major international scientific conference, the 10th World Congress on ADHD, May 8-11, 2025, in Prague, Czech Republic. Mentavi Health, founded in 2018, is an established innovator in evidence-based mental health solutions. Mentavi Chief Medical Officer Barry K. Herman, MD, MMM, will present clinical data from a study titled 'Validity of an Online Assessment of ADHD Among a Real-World Sample of Adults Seeking Web-Based Mental Healthcare.' Mentavi's study is the first of its kind to compare an asynchronous, web-based assessment against the current standard of care: a clinical interview, for diagnosing adult ADHD. 'Too many adults live for years with undiagnosed ADHD, often experiencing significant impairment in their personal and professional lives,' Herman said. 'This study demonstrates that validated digital tools can help close that gap and provide a credible first step toward care, especially for people who face barriers to traditional mental health services.' Millions of U.S. adults are believed to have ADHD. The U.S. Centers for Disease Control and Prevention (CDC) estimates the prevalence of ADHD 6.0 percent among adults. The study's manuscript is undergoing peer review and is expected to be published later in 2025. Herman will present key findings, including: 'Presenting this data at the World Congress on ADHD, to many of the world's leading experts on the disorder, will move the field forward for both the diagnosis of adult ADHD and for the value of telehealth,' Herman said. Mentavi Health's core mission is to increase access to accurate, efficient, and evidence-based mental health assessments. Mentavi leadership sees the presentation as supporting the company's mission through validating its technology, strengthening its clinical credibility, and building trust and a foundation for growth with stakeholders in healthcare and employer wellness. For more information, please visit Mentavi Health or ADHD Online. About Mentavi Health and ADHD Online Established as ADHD Online in 2018, Mentavi Health has evolved to encompass a broader range of mental health services. With the mission to make quality ADHD assessments accessible to all, Mentavi has grown to address not only ADHD but also the most common related mental health conditions. The nationwide Mentavi Smart Assessment and various treatment options showcase the company's commitment to providing comprehensive, accessible, compliant online mental health care. Contact InformationJessica Lombao SOURCE: Mentavi Health press release
